Europe
Sir Andrew Witty, the former head of GlaxoSmithKline, current president of UnitedHealth Group and chief executive officer of Optum, is temporarily stepping away from his duties to co-lead a World Health Organization effort to combat COVID-19.
It’s likely that more companies and universities will add additional assets as time goes on.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 14, 2020.
The two companies are eying the second half of this year to begin clinical trials on their combined project and, if the vaccine meets expectations, the companies said it could be available for use in the second half of 2021.
Although the COVID-19 death toll has not yet reached the numbers of H3N2, it still continues to climb.
It was a very busy week for clinical trial news. Here’s a look.
At least three different biotech companies are working on two ACE2-related drugs to find a solution to the COVID-19 pandemic.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 10, 2020.
Garching, 8th of April 2020 - VisionHealth GmbH, a pioneer for digital therapy support in inhalation therapy, announces the successful closing of a financing of 1 million Euro for market launch and future growth.
Biopharma companies strengthen their leadership teams and boards with this week’s Movers & Shakers.
PRESS RELEASES